Pharmacokinetics of Rifampin in TB/HIV Coinfected Women: Does Pregnancy Matter?
Background: Pregnant women are at high risk of progression from latent to active TB. They are typically treated with the same regimen as non-pregnant adults. Pregnancy, though, induces physiological changes that impact drug exposures. The effects of pregnancy on the pharmacokinetics (PK) of rifampin, the key sterilizing drug in anti-TB treatment, are unknown. Methods: Prospective…